ResMed News

ResMed Inc -- USA Stock  

USD 88.79  0.11  0.12%

Macroaxis does not monitor all media channels or aggregates social signals for ResMed. But even though we do not provide professional-grade financial sentiment analysis on ResMed Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ResMed. Additionally take a look at ResMed Hype Analysis, ResMed Correlation and ResMed Performance
  
a day ago at www.macroaxis.com         
Exercise or conversion by David Pendarvis of 5500 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
2 days ago at www.zacks.com         
Why Earnings Season Could Be Great for ResMed January 19, 2018
zacks News
Investors are always looking for stocks that are poised to beat at earnings season and ResMed Inc. may be one such company.
  
  
3 days ago at baxternewsreview.com         
Stock Watch Technicals in Focus For Resmed Inc
news
Baxter Review Get full coverage
  
  
few days ago at www.macroaxis.com         
Exercise or conversion by Rich Sulpizio of 12000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
few days ago at www.macroaxis.com         
Exercise or conversion by Jacobsen Stein of 37500 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
few days ago at www.macroaxis.com         
Acquisition by David Pendarvis of 7666 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
  
  
over a week ago at www.concordregister.com         
ResMed Inc. Stock Sees The Needle Move 0.10
news
ResMed Inc. closed at 87.78 after seeing 339181 shares trade hands during the most recent session. This represents a change of 0.75 percent from the opening.
  
  
over a week ago at finnewsweek.com         
RMI Signaling Increased Momentum For Resmed Inc
news
Investors and paying cloes attention to shares of Resmed Inc as the Relative Momentum Indicator or RMI has been spotted trending higher over the past week.
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by David Pendarvis of 6000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Sale by Brett Sandercock of 50000 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
  
  
over a week ago at www.streetobserver.com         
Neither buy nor sell rating on stock ResMed Inc.
news
ResMed Inc. stock price traded with surging change along with the volume 0.71 million shares in Monday trading session.
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by Michael Farrell of 30000 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over a week ago at www.macroaxis.com         
Exercise or conversion by David Pendarvis of 6364 shares of ResMed subject to Rule 16b-3
Macroaxis News
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
  
  
over two weeks ago at www.macroaxis.com         
Sale by Ronald Taylor of 10286 shares of ResMed
Macroaxis News
Filed transaction by Resmed Inc director. General open market or private sale of non-derivative or derivative security
  
  
over two weeks ago at www.concordregister.com         
Sale by Hollingshead James of 600 shares of ResMed
news
Filed transaction by Resmed Inc officer. General open market or private sale of non-derivative or derivative security
  
Price Growth (%)  
      Timeline 
1
ResMed Inc. ERP5 Score in Focus12/28/2017
2
Why Earnings Season Could Be Great for ResMed January 19, 20...01/19/2018

Earnings

ResMed Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.7April 25, 2017
ResMed Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Pair Trading

ResMed Pair Trading Analysis
Correlation analysis and pair trading evaluation for ResMed and DexCom Inc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Total Debt

ResMed Inc Total Debt
Based on latest financial disclosure ResMed Inc has Total Debt of 1.02 B. This is 57.49% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Total Debt for all stocks is 86.14% higher than the company.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.